As of 2025-07-10, the Relative Valuation of Poseida Therapeutics, Inc. (PSTX) is (8.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.50 USD, the upside of Poseida Therapeutics, Inc. based on Relative Valuation is -188.9%.
The range of the Relative Valuation is (6.43) - (11.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 18.7x | 13.3x |
| Forward P/E multiples | 10.3x - 21.3x | 13.8x |
| Fair Price | (6.43) - (11.68) | (8.45) |
| Upside | -167.7% - -223.0% | -188.9% |
| Date | P/E |